Details

Autor(en) / Beteiligte

• Nodari, Savina
• Manerba, Alessandra
• Vaccari, Alberto
• Milesi, Giuseppe
• Carubelli, Valentina
• Lazzarini, Valentina
• Lombardi, Carlo
• Ettori, Federica
• Metra, Marco
• Dei Cas, Alessandra

Titel

Six-year prognosis of diabetic patients with coronary artery disease

Ist Teil von

• European journal of clinical investigation, 2012-04, Vol.42 (4), p.376-383

Ort / Verlag

Oxford, UK: Blackwell Publishing Ltd

Erscheinungsjahr

2012

Quelle

Wiley-Blackwell Journals

Beschreibungen/Notizen

• Eur J Clin Invest 2012; 42 (4): 376–383 Background  Diabetes is associated with increased cardiovascular mortality. The aim of our study was to determine the prognostic factors for mortality in patients with type 2 diabetes (T2DM) and coronary artery disease (CAD) who underwent coronary angiography and percutaneous coronary intervention. Materials and methods  Four hundred and forty‐five consecutive T2DM patients with significant CAD (≥ 75% stenosis) were included in our analysis. All patients underwent standard clinical examination, laboratory tests and transthoracic echocardiography with measurement of the left ventricular ejection fraction. Severity of CAD at the coronary angiography was evaluated using the Gensini score. Clinical follow‐up was completed at 1, 3 and 6 years. Results  During a mean follow‐up of 73·3 ± 22·1 months, 109 patients died (24·5%). Significant determinants of an increased risk of death at multivariable analysis were age (p < 0·001), serum creatinine (p = 0·001), peripheral vascular disease (p = 0·002), serum glucose (p = 0·004), serum fibrinogen (p = 0·011) and history of heart failure (HF, p = 0·011). When all the variables were entered as categorical variables, with continuous variables split at their median value, only history of HF, estimated glomerular filtration rate, serum glucose, serum fibrinogen (all p < 0·0001) and beta‐blocker therapy at discharge (p = 0·027) were selected. Conclusions  Our study shows a relatively good prognosis of patients with T2DM. Comorbidities, namely HF and renal impairment, are main determinants of survival.